A meta-analysis of array-CGH studies implicates antiviral immunity pathways in the development of hepatocellular Carcinoma

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Guo, Xu ^a   Ba, Yanna ^b   Ma, Xi ^a   An, Jiaze ^b   Shang, Yukui ^a   Huang, Qichao ^a   Yang, Hushan ^c   Chen, Zhinan ^a   Xing, Jinliang ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GROWTH; CANCER TISSUE; CHROMOSOME 13Q; CHROMOSOME 14Q; CHROMOSOME 16Q; CHROMOSOME 17P; CHROMOSOME 17Q; CHROMOSOME 1Q; CHROMOSOME 20P; CHROMOSOME 4Q; CHROMOSOME 5P; CHROMOSOME 6P; CHROMOSOME 6Q; CHROMOSOME 8P; CHROMOSOME 8Q; CHROMOSOME 9P; CHROMOSOME 9Q; CHROMOSOME ABERRATION; CHROMOSOME MAP; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; COPY NUMBER VARIATION; DISEASE ASSOCIATION; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; VIRUS IMMUNITY; GENETIC DATABASE; GENETICS; IMMUNOLOGY; LIVER TUMOR; META ANALYSIS; PRECANCER; SIGNAL TRANSDUCTION; TUMOR GENE; VIROLOGY;

CARCINOMA, HEPATOCELLULAR; CHROMOSOME ABERRATIONS; COMPARATIVE GENOMIC HYBRIDIZATION; DATABASES, GENETIC; GENES, NEOPLASM; HUMANS; LIVER NEOPLASMS; PRECANCEROUS CONDITIONS; SIGNAL TRANSDUCTION;

EID: 83155191798     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028404     Document Type: Article

References (47)

1. Coleman WB, (2003) Mechanisms of human hepatocarcinogenesis. Curr Mol Med 3: 573-588.
2. Wong N, Lai P, Pang E, Leung TW, Lau JW, et al. (2000) A comprehensive karyotypic study on human hepatocellular carcinoma by spectral karyotyping. Hepatology 32: 1060-1068.
3. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, et al. (1992) Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258: 818-821.
4. Hermsen MA, Meijer GA, Baak JP, Joenje H, Walboomers JJ, (1996) Comparative genomic hybridization: a new tool in cancer pathology. Hum Pathol 27: 342-349.
5. Pollack JR, Perou CM, Alizadeh AA, Eisen MB, Pergamenschikov A, et al. (1999) Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nat Genet 23: 41-46.
6. Hashimoto K, Mori N, Tamesa T, Okada T, Kawauchi S, et al. (2004) Analysis of DNA copy number aberrations in hepatitis C virus-associated hepatocellular carcinomas by conventional CGH and array CGH. Mod Pathol 17: 617-622.
7. Yeh IT, Martin MA, Robetorye RS, Bolla AR, McCaskill C, et al. (2009) Clinical validation of an array CGH test for HER2 status in breast cancer reveals that polysomy 17 is a rare event. Mod Pathol 22: 1169-1175.
8. Tomioka N, Morita K, Kobayashi N, Tada M, Itoh T, et al. (2010) Array comparative genomic hybridization analysis revealed four genomic prognostic biomarkers for primary gastric cancers. Cancer Genet Cytogenet 201: 6-14.
9. Wilhelm M, Veltman JA, Olshen AB, Jain AN, Moore DH, et al. (2002) Array-based comparative genomic hybridization for the differential diagnosis of renal cell cancer. Cancer Res 62: 957-960.
10. Veltman JA, Fridlyand J, Pejavar S, Olshen AB, Korkola JE, et al. (2003) Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors. Cancer Res 63: 2872-2880.
11. Lamb JR, Zhang C, Xie T, Wang K, Zhang B, et al. (2011) Predictive genes in adjacent normal tissue are preferentially altered by sCNV during tumorigenesis in liver cancer and may rate limiting. PLoS One 6: e20090.
12. Okamura Y, Nomoto S, Hayashi M, Hishida M, Nishikawa Y, et al. (2011) Identification of the bleomycin hydrolase gene as a methylated tumor suppressor gene in hepatocellular carcinoma using a novel triple-combination array method. Cancer Lett 312: 150-157.
13. Carter NP, (2007) Methods and strategies for analyzing copy number variation using DNA microarrays. Nat Genet 39: S16-21.
14. Kusano N, Shiraishi K, Kubo K, Oga A, Okita K, et al. (1999) Genetic aberrations detected by comparative genomic hybridization in hepatocellular carcinomas: their relationship to clinicopathological features. Hepatology 29: 1858-1862.
15. Katoh H, Ojima H, Kokubu A, Saito S, Kondo T, et al. (2007) Genetically distinct and clinically relevant classification of hepatocellular carcinoma: putative therapeutic targets. Gastroenterology 133: 1475-1486.
16. Chochi Y, Kawauchi S, Nakao M, Furuya T, Hashimoto K, et al. (2009) A copy number gain of the 6p arm is linked with advanced hepatocellular carcinoma: an array-based comparative genomic hybridization study. J Pathol 217: 677-684.
17. Kim TM, Yim SH, Shin SH, Xu HD, Jung YC, et al. (2008) Clinical implication of recurrent copy number alterations in hepatocellular carcinoma and putative oncogenes in recurrent gains on 1q. Int J Cancer 123: 2808-2815.
18. Wu JC, Sun BS, Ren N, Ye QH, Qin LX, (2010) Genomic aberrations in hepatocellular carcinoma related to osteopontin expression detected by array-CGH. J Cancer Res Clin Oncol 136: 595-601.
19. Katoh H, Shibata T, Kokubu A, Ojima H, Loukopoulos P, et al. (2005) Genetic profile of hepatocellular carcinoma revealed by array-based comparative genomic hybridization: identification of genetic indicators to predict patient outcome. J Hepatol 43: 863-874.
20. Guan XY, Fang Y, Sham JS, Kwong DL, Zhang Y, et al. (2000) Recurrent chromosome alterations in hepatocellular carcinoma detected by comparative genomic hybridization. Genes Chromosomes Cancer 29: 110-116.
21. Edamoto Y, Hara A, Biernat W, Terracciano L, Cathomas G, et al. (2003) Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosis. Int J Cancer 106: 334-341.
22. Nishida N, Fukuda Y, Komeda T, Kita R, Sando T, et al. (1994) Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma. Cancer Res 54: 3107-3110.
23. Ioannidis JP, Lau J, (1999) Pooling research results: benefits and limitations of meta-analysis. Jt Comm J Qual Improv 25: 462-469.
24. Jong K, Marchiori E, van der Vaart A, Chin SF, Carvalho B, et al. (2007) Cross-platform array comparative genomic hybridization meta-analysis separates hematopoietic and mesenchymal from epithelial tumors. Oncogene 26: 1499-1506.
25. Patil MA, Gutgemann I, Zhang J, Ho C, Cheung ST, et al. (2005) Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma. Carcinogenesis 26: 2050-2057.
26. Kakar S, Chen X, Ho C, Burgart LJ, Adeyi O, et al. (2009) Chromosomal abnormalities determined by comparative genomic hybridization are helpful in the diagnosis of atypical hepatocellular neoplasms. Histopathology 55: 197-205.
27. Schlaeger C, Longerich T, Schiller C, Bewerunge P, Mehrabi A, et al. (2008) Etiology-dependent molecular mechanisms in human hepatocarcinogenesis. Hepatology 47: 511-520.
28. Zhang NR, Senbabaoglu Y, Li JZ, (2010) Joint estimation of DNA copy number from multiple platforms. Bioinformatics 26: 153-160.
29. Chari R, Lockwood WW, Lam WL, (2006) Computational methods for the analysis of array comparative genomic hybridization. Cancer Inform 2: 48-58.
30. Kanehisa M, Goto S, (2000) KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28: 27-30.
31. Kaposi-Novak P, Libbrecht L, Woo HG, Lee YH, Sears NC, et al. (2009) Central role of c-Myc during malignant conversion in human hepatocarcinogenesis. Cancer Res 69: 2775-2782.
32. Yamamoto Y, Chochi Y, Matsuyama H, Eguchi S, Kawauchi S, et al. (2007) Gain of 5p15.33 is associated with progression of bladder cancer. Oncology 72: 132-138.
33. Wang T, Chen YH, Hong H, Zeng Y, Zhang J, et al. (2009) Increased nucleotide polymorphic changes in the 5′-untranslated region of delta-catenin (CTNND2) gene in prostate cancer. Oncogene 28: 555-564.
34. Kang JU, Koo SH, Kwon KC, Park JW, (2010) Frequent silence of chromosome 9p, homozygous DOCK8, DMRT1 and DMRT3 deletion at 9p24.3 in squamous cell carcinoma of the lung. Int J Oncol 37: 327-335.
35. Yeh SH, Wu DC, Tsai CY, Kuo TJ, Yu WC, et al. (2006) Genetic characterization of fas-associated phosphatase-1 as a putative tumor suppressor gene on chromosome 4q21.3 in hepatocellular carcinoma. Clin Cancer Res 12: 1097-1108.
36. Pehlivan D, Gunduz E, Gunduz M, Nagatsuka H, Beder LB, et al. (2008) Loss of heterozygosity at chromosome 14q is associated with poor prognosis in head and neck squamous cell carcinomas. J Cancer Res Clin Oncol 134: 1267-1276.
37. Zondervan PE, Wink J, Alers JC, JN IJ, Schalm SW, et al. (2000) Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias. J Pathol 192: 207-215.
38. Villanueva A, Chiang DY, Newell P, Peix J, Thung S, et al. (2008) Pivotal role of mTOR signaling in hepatocellular carcinoma. Gastroenterology 135: 1972-1983, 1983 e1971-1911.
39. Zaret KS, Grompe M, (2008) Generation and regeneration of cells of the liver and pancreas. Science 322: 1490-1494.
40. Thompson MD, Monga SP, (2007) WNT/beta-catenin signaling in liver health and disease. Hepatology 45: 1298-1305.
41. Sicklick JK, Li YX, Jayaraman A, Kannangai R, Qi Y, et al. (2006) Dysregulation of the Hedgehog pathway in human hepatocarcinogenesis. Carcinogenesis 27: 748-757.
42. Tada M, Kanai F, Tanaka Y, Tateishi K, Ohta M, et al. (2008) Down-regulation of hedgehog-interacting protein through genetic and epigenetic alterations in human hepatocellular carcinoma. Clin Cancer Res 14: 3768-3776.
43. Guidotti LG, Chisari FV, (2001) Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 19: 65-91.
44. Kubler K, Arndt PF, Wardelmann E, Landwehr C, Krebs D, et al. (2008) Genetic alterations of HLA-class II in ovarian cancer. Int J Cancer 123: 1350-1356.
45. Chung MY, Wu JC, Chau GY, Lui WY, Tsay SH, et al. (2000) Preferentially deleted chromosome region 9p21 in large hepatocellular carcinomas. Int J Mol Med 5: 521-524.
46. Cai T, Nesi G, Dal Canto M, Tinacci G, Mondaini N, et al. (2010) Loss of heterozygosis on IFN-alpha locus is a prognostic indicator of bacillus Calmette-Guerin response for nonmuscle invasive bladder cancer. J Urol 183: 1738-1743.
47. Roman E, Meza-Zepeda LA, Kresse SH, Myklebost O, Vasstrand EN, et al. (2008) Chromosomal aberrations in head and neck squamous cell carcinomas in Norwegian and Sudanese populations by array comparative genomic hybridization. Oncol Rep 20: 825-843.